Verastem Oncology | BiotechTV

top of page

Verastem's CEO Dan Paterson discusses the launch of the Avmapki Fakzynja Co-Pack for KRAS-mutated recurrent low-grade serous ovarian cancer, and other pipeline projects

He discusses the launch of this combination, which was an accelerated approval, and arrived a couple of months sooner than the scheduled...

Sep 8

Verastem Oncology's CEO comments on a volatile week and #ASCO24 data in pancreatic cancer

Dan Paterson gives background on the rolling submission the company started this week in a type of ovarian cancer, with his thoughts on...

Company News

Jun 1, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Verastem's CEO Dan Paterson discusses the launch of the Avmapki Fakzynja Co-Pack for KRAS-mutated recurrent low-grade serous ovarian cancer, and other pipeline projects

Verastem Oncology's CEO comments on a volatile week and #ASCO24 data in pancreatic cancer

Follow BiotechTV

Sponsors

Sponsor Spotlight